|
Daniel G. Anderson
Massachusetts Institute of Technology
Michael J. Cima
Massachusetts Institute of Technology
Allan Hoffman
University of Washington
Daniel S. Kohane
Children’s Hospital Boston
Tsuneji Nagai
Nagai Foundation Tokyo
Amir Nashat
Polaris Venture Partners
Michael Sefton
University of Toronto
Larry Sternson
Consultant
Yasuhiko Tabata
Kyoto University
Yoshinobu Baba
Professor, Nagoya University
Nanotechnology for cancer stem cell diagnosis and in vivo stem cell imaging for tissue engineering
Gerald Bernstein
Vice President, Medical Affairs and Director, Generex Biotechnology Corp.
The more we know the more complex it gets: Diabetes, a moving target
Henry Brem
Director of Neurosurgery and Professor, Johns Hopkins School of Medicine
New approaches for treating brain tumors
Christine Bunt
Chief Operating Officer and Founder, TARIS Biomedical
Drug-device convergence for diseases of the bladder
Joseph DeSimone
Chancellor’s Eminent Professor of Chemistry; Kenan Jr. Distinguished Professor of Engineering, University of North Carolina-Chapel Hill
Translating the precision of microelectronics to the production of highly uniform shape-specific carriers for vaccines, biologics and small molecule drug
Oliver Fetzer
President and Chief Executive Officer, Cerulean Pharma, Inc.
Advances in the development of nanopharmaceuticals
Koji Hanai
Scientist, Dainippon Sumitomo Pharma Co., Ltd.
Progress of atelocollagen-mediated drug delivery systems for nucleic acid medicines
Jeff Hrkach
Vice President, Pharmaceutical Sciences, BIND Biosciences, Inc.
The development of BIND targeted nanotherapeutics
Kenji Hyodo
Scientist, Eisai Co., Ltd.
Inhibition of cancer metastasis by targeted delivery of antioxidant enzymes
Juichi Ito
Professor and Chairman of the Department of Otolaryngology-Head and Neck Surgery, Kyoto University
New drug delivery systems for inner ear diseases
Shaoyi Jiang
Professor, University of Washington; SAB Co-Chair, Semprus BioSciences; Professor, University of Washington
Betaine Polymers for reducing medical device complications and enhancing drug delivery
Lloyd Johnston
Vice President, Pharmaceutical Research and Development, Selecta Biosciences, Inc.
Multifunctional immunomodulatory nanoparticles for therapeutic vaccines
Yasufumi Kaenda
Professor, Osaka University
Novel anti-cancer strategies using HVJ (Sendai virus) envelope
Kazunori Kataoka
Professor, University of Tokyo
Block copolymer micelles and vesicles as nanocarriers for gene and drug delivery
Shigeru Kawakami
Assistant Professor, Kyoto University
Development and evaluation of organ-press mediated in vivo gene transfection methods of plamid DNA and siRNA
Joseph Kim
President and Chief Executive Officer, Inovio Biomedical Corporation
Electric fields for vaccine delivery: How in vivo electroporation could fulfill the promise of DNA vaccines
Sung Wan Kim
Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry, University of Utah
Newly designed polymers for the delivery of siRNA
Young Keun Kim
Professor, Korea University; President, Korea University Research and Business Foundation
Multifunctional nanostructured materials for biomedical applications
Victor Kotelianski
Senior Vice President of Research, Alnylam Pharmaceuticals
Progress in the development of delivery systems for siRNA
Christopher Loose
Chief Technology Officer, Semprus BioSciences
Betaine Polymers for reducing medical device complications and enhancing drug delivery
Hideyuki Okano
Professor and Chairman, Department of Physiology, Keio University
Strategies toward CNS-Regeneration using IPS cell technology
Maria Palasis
Executive Vice President, Research and Development, Arsenal Medical
Combination products in drug delivery: Enabling site specific therapy with medical devices
Rodney Pearlman
Twenty years of protein drug delivery: The good, the bad, the ugly
Ronald Peeples
Vice President, Pharmaceutical R&D and Supplies, Pfizer BioTherapeutics
Development of advanced drug delivery products for biotherapeutics
Nicholas Peppas
Fletcher Stuckey Pratt Chair in Engineering, University of Texas-Austin
Recognition and delivery: The next generation of medical microdevices
John Patton
Founder & Chief Scientific Officer, Dance Pharma
Inhaled medicines for systemic action
Howard Rosen
Lecturer, Department of Chemical Engineering, Stanford University
Ouch! The role of drug delivery in pain management
John Santini
President & Chief Executive Officer, MicroCHIPS, Inc.
Addressing drug delivery challenges with intelligent implantable devices
Yuichi Sugiyama
Professor, University of Tokyo
Evolutional drug development with the use of microdosing clinical trial: Quantitative prediction of ADME and PET imaging
Francis Szoka
Professor of Biopharmaceutical Sciences, University of California, San Francisco
Back to the future: New lipids to solve an old problem: Drug and nucleic acid delivery
Eric Tomlinson
President and Chief Executive Officer, Altea Therapeutics Corp.
The efficient transdermal delivery of biotherapeutics from a conventional skin patch
Yasuyoshi Watanabe
Director, RIKEN Center for Molecular Imaging Science
Drug delivery systems and PK/PD studies with molecular imaging
Takayuki Yoshida
Scientist, Astellas Pharma, Inc.
pH-sensitive PEG release from nanoparticles for gene delivery
[Back to Top]
|
